This inventor holds 1 USPTO granted patent. Top assignee: Agennix Ag. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Christoph Schaab: Innovator in Cancer Treatment
Introduction
Christoph Schaab is a notable inventor based in Munich, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Schaab holds a patent for an "Anti-proliferative combination therapy using certain platinum-based chemotherapeutic agents and EGFR inhibitors or pyrimidine analogues." This invention describes a method for the prevention and treatment of cancer or tumors. It focuses on a combination therapy that includes an inhibitor of receptors from the EGFR family or a chemotherapeutically active pyrimidine analogue, along with specific platinum-based chemotherapeutic agents. His work in this area is crucial for advancing cancer treatment options.
Career Highlights
Christoph Schaab is associated with Agennix AG, a company dedicated to developing innovative therapies for cancer. His role at Agennix AG has allowed him to contribute to groundbreaking research and the development of effective treatment methods.
Collaborations
Schaab has collaborated with several professionals in his field, including Katja Wosikowski-Buters and Marino Schuhmacher. These collaborations have enhanced the research and development process, leading to more effective cancer therapies.
Conclusion
Christoph Schaab's work in cancer treatment exemplifies the impact of innovative thinking in medicine. His patent and contributions to Agennix AG highlight the importance of collaboration and research in developing effective therapies for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile